Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis

Hepatic fibrosis can result as a pathological response to nonalcoholic steatohepatitis (NASH). Cirrhosis, the late stage of fibrosis, has been linked to poor survival and an increased risk of developing hepatocellular carcinoma, with limited treatment options available. Therefore, there is an unmet...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cells
Main Authors: Simón Serrano, Sonia, Grönberg, Alvar, Longato, Lisa, Rombouts, Krista, Kuo, Joseph, Gregory, Matthew, Moss, Steven, Elmér, Eskil, Mazza, Giuseppe, Gallay, Philippe, Pinzani, Massimo, Hansson, Magnus J., Massoumi, Ramin
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6912624/
https://ncbi.nlm.nih.gov/pubmed/31717385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells8111409
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados